Filling the need for trusted information on national health issues…

New Dengue Vaccine Could Protect People From Disease If Targeted Accurately

Thomson Reuters Foundation: Dengue vaccine no silver bullet but worth a shot for those who need it most
Stefan Flasche, assistant professor at the London School of Hygiene & Tropical Medicine’s department of infectious disease epidemiology

“…A new London School of Hygiene & Tropical Medicine-led study published in the journal PLOS Medicine, initiated by the World Health Organization, and conducted with a team of international experts … showed that giving [the CYD-TDV dengue vaccine] only to those populations with a high burden of disease has the potential to prevent about one out of five dengue hospitalizations. It predicts that a substantial positive impact of vaccination can be achieved if targeted at individuals who most likely had an infection before and, if priced competitively, a cost-effectiveness profile that is similar to that of other vaccines currently in use. … The global health community must ensure that we are in a position to make best use of this dengue vaccine until other, more effective means of prevention become available. CYD-TDV is no silver bullet, but if targeted accurately it will bring help to those who need it most” (11/29).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.